Abstract
In hereditary nonpolyposis colorectal cancer (HNPCC) syndrome, more than 90% of the carcinomas show microsatellite instability (MSI) due to a loss of mismatch repair (MMR) function. Although adenomas are very common in HNPCC and demonstrate an accelerated adenoma–carcinoma sequence, data about the prevalence and development of MSI in these early neoplastic lesions are lacking. To determine whether MSI and loss of MMR-protein expression are already present in early stages of tumorigenesis and could therefore be used as a screening tool to identify HNPCC patients before they develop an invasive carcinoma, we analyzed 71 adenomas of 36 HNPCC patients during a 5-year follow-up study. These 36 patients were part of a cohort of 122 HNPCC patients who were investigated at the Institute of Pathology, Klinikum Kassel, as part of the multicentric German HNPCC Consortium, which currently serves more than 2,880 registered families. The diagnosis of HNPCC was based either on the detection of a pathogenic germline mutation in the MSH2, MLH1, or MSH6 genes or in cases where a pathogenic mutation was not found; diagnosis of HNPCC was made, because all patients fulfilled the Amsterdam or Bethesda criteria and revealed a high degree of MSI (MSI-H) as well as loss of one of the MMR proteins by IHC in the cancer tissue. We found that most adenomas (58/71) were MSI-H and had loss of MMR-protein expression. Of the 71 adenomas, 3 were MSI-H with expression of all MMR proteins, and 3 out of 71 displayed loss of a MMR protein with the microsatellites being classified as microsatellite stable (MSS). However, 7 of the 31 adenomas that were located more than 5 cm away from the carcinoma revealed an MSS status (n=6) or low in MSI (n=1) and expressed all MMR proteins. In summary, a significant percentage of HNPCC-associated adenomas (7/31, 22.6%) developing at a distance of more than 5 cm from the corresponding carcinoma did not show the MSI-H MMR-deficient phenotype and expressed all MMR genes. To our knowledge, this is the first study that shows that in most HNPCC patients, the mutator pathway is already detectable in adenomas, but MMR-proficient adenomas can also be found. Therefore, screening for MMR deficiency should not be applied routinely in adenomas with the goal to identify HNPCC patients.
Similar content being viewed by others
References
Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomäki P, Chadwick RB, Kääriäinen H, Eskelinen M, Järvinen H, Mecklin JP, Chapelle de la A et al (1998) Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338:1481–1487
Evans DG, Walsh S, Jeacock J (1997) Incidence of hereditary non-polyposis colorectal cancer in a population-based study of 1137 consecutive cases of colorectal cancer. Br J Surg 84:1281–1285
Lynch HT, Chapelle de la A (2003) Hereditary colorectal cancer. N Engl J Med 348:919–932
Salovaara R, Loukola A, Kristo P, Kääriäinen H, Ahtola H, Eskelinen M, Härkönen N, Julkunen R, Kangas E, Ojala S, Tulikoura J, Valkamo E, Järvinen H, Mecklin JP, Aaltonen LA, de la Chapelle A (2000) Population-based molecular detection of hereditary nonpolyposis colorectal cancer. J Clin Oncol 11:2193–2200
Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, de la Chapelle A, Peltomäki P, Mecklin JP, Jarvin HJ (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 8:214–218
Holmberg M, Kristo P, Chadwicks RB, Mecklin JP, Jarvinen H, de la Chapelle A, Nystrom-Lahti M, Peltomaki P (1998) Mutation sharing, predominant involvement of the MLH1 gene and description of four novel mutations in hereditary nonpolyposis colorectal cancer. Mutations in brief no. 144. Hum Mutat 1:482–486 (online)
Mangold E, Pagenstecher C, Friedl W, Mathiak M, Buettner R, Engel C, Loeffler M, Holinski-Feder E, Muller-Koch Y, Keller G, Schackert HK, Kruger S, Goecke T, Moeslein G, Kloor M, Gebert J, Kunstmann E, Schulmann K, Ruschoff J, Propping P (2004) Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1721 German families suspected of hereditary nonpolyposis colorectal cancer. Int J Cancer 116(5):692–702
Plaschke J, Krüger ST, Pistorius ST, Theissig F, Saeger HD, Schackert HK (2002) Involvement of hMSH6 in the development of hereditary and sporadic colorectal cancer revealed by immunostaining is based on germline mutations, but rarely on somatic inactivation. Int J Cancer 97:643–648
Peltomäki P (2001) Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 10:735–740
Loeb LA (1991) Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51:3075–3079
Thibodeau SN, Bren G, Schaid D (1993) Microsatellite instability in cancer of the proximal colon. Science 260:816–819
Peltomäki P (2001) Deficient DNA mismatch repair: a common etiologic factor for colon cancer. Hum Mol Genet 10:735–740
Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363:558–561
Cunningham JM, Christensen ER, Tester DJ, Kim CY, Roche PC, Burgart LJ, Thibodeau SN (1998) Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res 58:3455–3460
Lamberti C, Kruse R, Ruelfs C, Caspari R, Wang Y, Jungck M, Mathiak M, Malayeri HR, Friedl W, Sauerbruch T, Propping P (1999) Microsatellite instability—a useful diagnostic tool to select patients at high risk for hereditary non-polyposis colorectal cancer: a study in different groups of patients with colorectal cancer. Gut 44:839–843
Loukola A, Eklin K, Laiho P, Salovaara R, Kristo P, Järvinen H, Mecklin JP, Launonen V, Aaltonen LA (2001) Microsatellite marker analysis in screening for hereditary nonpolyposis colorectal cancer (HNPCC). Cancer Res 61:4545–4549
Rüschoff J, Bocker T, Schlegel J, Stamm G, Hofstaedter F (1995) Microsatellite instability: new aspects in the carcinogenesis of colorectal carcinoma. Virchows Arch 426:215–222
Lanza G, Gafà R, Maestri I, Santini A, Matteuzzi M, Cavazzini L (2002) Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability. Mod Pathol 15:741–749
Jass JR (2000) hMLH1 and hMSH2 immunostaining in colorectal cancer. Gut 47:315–316
Müller W, Burgart LJ, Krause-Paulus R, Thibodeau SN, Almeida M, Bocker Edmonston T, Boland CR, Sutter C, Jass JR, Lindblom A, Lubinski J, MacDermot K, Sanders DSA, Morreau H, Müller A, Oliani C, Orntoft T, Ponz De Leon M, Rosty C, Rodriguez-Bigas M, Rüschoff J, Ruszkiewicz A, Sabourin J, Salovaara R, Möslein G; ICG-HNPCC (2001) The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)—results of an international collaborative study. Fam Cancer 1:87–92
Thibodeau SN, French AJ, Roche PC, Roche PC, Cunningham JM, Tester DJ, Lindor NM, Moslein G, Baker SM, Liskay RM, Burgart LJ, Honchel R, Halling KC (1996) Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 56:4836–4840
Gryfe R, Gallinger S (2001) Microsatellite instability, mismatch repair deficiency, and colorectal cancer. Surgery 130:17–20
Aaltonen LA, Peltomäki P, Mecklin JP, Jarvinen H, Jass JR, Green JS, Lynch HT, Watson P, Tallqvist G, Juhola M (1994) Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal patients. Cancer Res 54:1645–1648
Loukola A, Salovaara R, Kristo P, Moisio A-L, Kääriäinen H, Ahtola H, Eskelinen M, Härkönen N, Julkunen R, Kangas E, Ojala S, Tulikoura J, Valkamo E, Järvinen H, Mecklin J-P, de la Chapelle A, Aaltonen LA (1999) Microsatellite instability in adenomas as a marker for hereditary nonpolyposis colorectal cancer. Am J Pathol 155:1849–1853
Young J, Leggett B, Gustafson C, Ward M, Searle J, Thomas L, Buttenshaw R, Chenevix-Trench G (1993) Genomic instability occurs in colorectal carcinomas but not in adenomas. Hum Mutat 2:351–354
Jacoby RF, Marshall DJ, Kailas S, Schlack S, Harms B, Love R (1995) Genetic instability associated with adenoma to carcinoma progression in hereditary nonpolyposis colon cancer. Gastroenterology 109:73–82
Hamilton SR, Aaltonen LA (eds) (2000) Pathology and genetics of tumours of the digestive system. World health organization classification of tumours. IARC Press, Lyon
Vasen HFA, Watson P, Mecklin J-P, Lynch HT, the ICG-HNPCC (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology 116:1453–1456
Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, Srivastava S (1998) A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58:5248–5257
Umar A, Boland CR, Terdiman JP, Syngal S, Chapelle de la A, Rüschoff J, Fishel R, Lindor NM, Burgart LJ, Hamelin R, Hamilton SR, Hiatt RA, Jass J, Lindblom A, Lynch HT, Peltomaki P, Ramsey SD, Rodriguez-Bigas MA, Vasen HFA, Hawk ET, Barett JC, Freedman AN, Srivastava S (1999) New clinical criteria for Hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the international collaborative group on HNPCC. Gastroenterology 116:1453–1456
Müller A, Giuffre G, Bocker Edmonston T, Mathiak M, Roggendorf B, Heinmöller E, Brodegger T, Tuccari G, Mangold E, Buettner R, Rüschoff J; German HNPCC Consortium, German Cancer Aid (Deutsche Krebshilfe) (2004) Challenges and pitfalls in HNPCC screening by microsatellite analysis and immunohistochemistry. J Mol Diagn 6:308–315
Jass JR, Stewart SM, Stewart J, Lane MR (1994) Hereditary non-polyposis colorectal cancer: morphologies, genes and mutations. Mutat Res 290:125–133
Rijcken FE, Hollema H, Kleibeuker JH (2002) Proximal adenomas in hereditary non-polyposis colorectal cancer prone to rapid malignant transformation. Gut 50:382–386
Heinmöller E, Renke B, Beyser K, Dietmaier W, Langner C, Rüschoff J (2001) Pitfalls in diagnostic molecular pathology—significance of sampling error. Virchows Arch 439:504–511
Giuffre G, Müller A, Brodegger T, Bocker Edmonston T, Gebert J, Kloor M, Dietmaier W, Kullmann F, Büttner R, Tuccari G, Rüschoff J; German HNPCC Consortium (2005) Microsatellite analysis of hereditary nonpolyposis colorectal cancer-associated colorectal adenomas by laser-assisted microdissection: correlation with mismatch repair protein expression provides new insights in early steps of tumorigenesis. J Mol Diagn 7:160–170
Wahlberg SS, Schmeits J, Thomas G, Loda M, Garber J, Syngal S (2002) Evaluation of microsatellite instability and immunohistochemistry for the prediction of germ-line MSH2 and MLH1 mutations in hereditary nonpolyposis colon cancer families. Cancer Res 62:3485–3492
Lanza G, Gafà R, Maestri I, Santini A, Matteuzzi M, Cavazzini L (2002) Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability. Mod Pathol 15:741–749
Pedroni M, Sal E, Scarselli A, Borghi F, Menigatti M, Benatti P, Percesepe A, Rossi G, Foroni M, Losi L, DiGregorio C, De Pol A, Nascimbeni R, Di Betta E, Salerni B, Ponz de Leon M, Roncucci L (2001) Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis. Cancer Res 61:896–899
Acknowledgements
This work was supported by the German Cancer Aid (Deutsche Krebshilfe) to J.R. and R.B. (grant 70-2401-Rü), the Deutsche Forschungsgemeinschaft to R.B. (Bu 672/10-1, 10-2), the German Ministry for Education and Research (BMBF) to J.R. (grant AN 020113007601).
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
An invited commentary on this paper is available at http://dx.doi.org/10.1007/s00384-005-0081-6
See Appendix A for a list of the members of this consortium.
Appendix
Appendix
The German HNPCC Consortium consists of the following centers (in alphabetical order): clinical centers in Bochum (in addition to the following authors: Jörg T. Epplen, Stefan Hahn, Erdmute Kunstmann, Christian Pox, and Jörg Willert), Bonn (in addition to the following authors: Elisabeth Mangold, Constanze Pagenstecher, Waltraut Friedl, Holger Lauschke, Andreas Hirner, Christof Lamberti, Peter Propping, and Tilman Sauerbruch), Düsseldorf (in addition to author PD G. Möslein, M.D.), Dresden (in addition to the following authors: Daniela E. Aust, Friedrich Balck, Ruth Höhl, Friedmar R. Kreuz, Stefan Krüger, Steffen R. Pistorius, and Jens Plaschke), Heidelberg (in addition to author Prof. Magnus von Knebel-Döberitz), München-Regensburg (in addition to the following authors: Wolfgang Dietmaier, Reinhard Kopp, Peter Lohse, Michael Muders, Yvonne Müller-Koch, and Holger Vogelsang), center for reference pathology Kassel (in addition to author Thomas Brodegger), and center for documentation and biometry in Leipzig (in addition to the following authors: Christoph Engel, Jochen Forberg, Marlies Herold, and Markus Löffler).
Rights and permissions
About this article
Cite this article
German HNPCC Consortium., Müller, A., Beckmann, C. et al. Prevalence of the mismatch-repair-deficient phenotype in colonic adenomas arising in HNPCC patients: results of a 5-year follow-up study. Int J Colorectal Dis 21, 632–641 (2006). https://doi.org/10.1007/s00384-005-0073-6
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-005-0073-6